Daiwa Securities Group
EBS icon

Daiwa Securities Group’s Emergent Biosolutions EBS Stock Holding History

Daiwa Securities Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,346
Closed -$117K – 1404
2021
Q3 		$117K Sell
2,346
-1,377
-37% -$83.4K ﹤0.01% 985
2021
Q2 		$235K Sell
3,723
-556
-13% -$35.7K ﹤0.01% 920
2021
Q1 		$398K Buy
+4,279
New +$438K ﹤0.01% 847
2020
Q4 		– Sell
-300
Closed -$31K – 1264
2020
Q3 		$31K Buy
+300
New +$32.3K ﹤0.01% 962

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Daiwa Securities Group's EBS Position: Q4 2021 in Review

Daiwa Securities Group sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 2,346 shares — an estimated $117K sold.

Daiwa Securities Group first reported a position in EBS in Q3 2020 and held it in 4 quarters. The position peaked at $398K in Q1 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Daiwa Securities Group reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 2,346 Emergent Biosolutions shares in Q4 2021, an estimated $117K.
  • Daiwa Securities Group first reported a position in Emergent Biosolutions in Q3 2020 and held it in 4 quarters.
  • Daiwa Securities Group's Emergent Biosolutions position peaked at $398K in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.